BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36417044)

  • 1. The Development and Evaluation of Phase Transition Microemulsion for Ocular Delivery of Acetazolamide for Glaucoma Treatment.
    Abd El Wahab LM; Essa EA; El Maghraby GM; Arafa MF
    AAPS PharmSciTech; 2022 Nov; 24(1):1. PubMed ID: 36417044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of microemulsions as prolonged-release injectables through in-situ phase transition.
    Wu Z; Alany RG; Tawfeek N; Falconer J; Zhang W; Hassan IM; Rutland M; Svirskis D
    J Control Release; 2014 Jan; 174():188-94. PubMed ID: 24316265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery.
    Ren X; Svirskis D; Alany RG; Zargar-Shoshtari S; Wu Z
    Int J Pharm; 2012 Jul; 431(1-2):130-7. PubMed ID: 22548845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
    Hegde RR; Bhattacharya SS; Verma A; Ghosh A
    Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once Daily Pregabalin Eye Drops for Management of Glaucoma.
    Ibrahim MM; Maria DN; Mishra SR; Guragain D; Wang X; Jablonski MM
    ACS Nano; 2019 Dec; 13(12):13728-13744. PubMed ID: 31714057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of water-in-oil microemulsions with the potential of prolonged release for oral delivery of L-glutathione.
    Wen J; Du Y; Li D; Alany R
    Pharm Dev Technol; 2013; 18(6):1424-9. PubMed ID: 23742726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
    Bharti SK; Kesavan K
    Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation.
    Chan J; Maghraby GM; Craig JP; Alany RG
    Int J Pharm; 2007 Jan; 328(1):65-71. PubMed ID: 17092668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
    Verma P; Gupta RN; Jha AK; Pandey R
    Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study.
    Gautam N; Kesavan K
    Curr Eye Res; 2021 Dec; 46(12):1844-1852. PubMed ID: 34176380
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide.
    Morsi N; Ibrahim M; Refai H; El Sorogy H
    Eur J Pharm Sci; 2017 Jun; 104():302-314. PubMed ID: 28433750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation.
    Thakkar PJ; Madan P; Lin S
    Pharm Dev Technol; 2014 May; 19(3):373-84. PubMed ID: 23634780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
    Mishra V; Jain NK
    Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water in nigella oil microemulsion for enhanced oral bioavailability of linagliptin.
    Eid RK; Arafa MF; El Maghraby GM
    Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38740693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of self-microemulsifying and microemulsion systems for protection of prednisolone from gamma radiation.
    El Maghraby GM; Bosela AA
    Pharm Dev Technol; 2011 Jun; 16(3):237-42. PubMed ID: 20148711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase transition of a microemulsion upon addition of cyclodextrin - applications in drug delivery.
    Thakur SS; Solloway J; Stikkelman A; Seyfoddin A; Rupenthal ID
    Pharm Dev Technol; 2018 Feb; 23(2):167-175. PubMed ID: 28828910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cow ghee fortified ocular topical microemulsion;
    Gupta A; Nayak K; Misra M
    J Microencapsul; 2019 Nov; 36(7):603-621. PubMed ID: 31500482
    [No Abstract]   [Full Text] [Related]  

  • 19. Equivalence of conventional and sustained release oral dosage formulations of acetazolamide in primary open angle glaucoma.
    Joyce PW; Mills KB; Richardson T; Mawer GE
    Br J Clin Pharmacol; 1989 May; 27(5):597-606. PubMed ID: 2757882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
    Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
    Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.